Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
1 September 1995 | Volume 123 Issue 5 | Pages 392-393
In his editorial on minocycline treatment of rheumatoid arthritis, Dr. Paulus compares the favorable outcome to the outcome seen with treatment of a smoldering chronic infection [1]. The partial remission induced by minocycline therapy and relapse following its discontinuation suggest that antibiotic responsiveness may actually address a secondary "infection" induced by nonsteroidal anti-inflammatory drugs (NSAIDs) taken by all patients throughout the Monocycline in Rheumatoid Arthritis (MIRA) clinical trial [2]. Long-term NSAID exposure produces intestinal hyperpermeability and inflammation, which cannot be reversed by misoprostol but which is both prevented and reversed by the administration of metronidazole [3]. Therapy with NSAIDs to treat rheumatoid arthritis increases patients' antibody levels to Clostridium perfringens and its
1. Paulus HE. Minocycline treatment of rheumatoid arthritis [Editorial]. Ann Intern Med. 1995; 122:147-8.
2. Tilley BC, Alarcon GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. Ann Intern Med. 1995; 122:81-9.
3. Davies GR, Wilkie ME, Rampton DS. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig Dis Sci. 1993; 38:417-25.
4. Dearlove M, Barr K, Neuman V, Bird HA, Gool HC, Wright V. The effect of non-steroidal anti-inflammatory drugs of faecal flora nd bacterial antibody levels in rheumatoid arthritis. Br J Rheumatol. 1992; 31:443-7.
5. Severijnen AJ, Kool J, Swack AJ, Hazenberg MP. Intestinal flora of patients with rheumatoid arthritis: induction of chronic arthritis in rats by cell wall fragments of Eubacterium aerofaciens strain. Br J Rheumatol. 1990; 29:433-9. About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
LETTER
Minocycline and Rheumatoid Arthritis Revisited
TO THE EDITOR:
toxin [4]. Bacterial cell-wall polymers isolated from normal enteric anaerobes can induce chronic arthritis in experimental animals [5]. Therapy with NSAIDs increases intestinal permeability and allows sensitization to components of the indigenous flora of the gut; these actions may not only cause an inflammatory enteritis, reversible by antibiotic agents but may aggravate inflammatory arthritis, a condition also reversible by antibiotic agents. This theory can be readily tested by comparing changes in intestinal lactulose permeability and stool leukocyte counts with changes in clinical variables.
Author and Article Information
![]()
Top
Author & Article Info
References
New York, NY 10021
References
![]()
Top
Author & Article Info
References
![]()
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
| |||||||||||||||||||||||||||||||||||||||||||||||||